214 related articles for article (PubMed ID: 14751088)
1. Mammalian target of rapamycin (mTOR) Inhibitors.
Dutcher JP
Curr Oncol Rep; 2004 Mar; 6(2):111-5. PubMed ID: 14751088
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin: a new molecular target for breast cancer.
Mita MM; Mita A; Rowinsky EK
Clin Breast Cancer; 2003 Jun; 4(2):126-37. PubMed ID: 12864941
[TBL] [Abstract][Full Text] [Related]
3. Current status and challenges associated with targeting mTOR for cancer therapy.
Dowling RJ; Pollak M; Sonenberg N
BioDrugs; 2009; 23(2):77-91. PubMed ID: 19489650
[TBL] [Abstract][Full Text] [Related]
4. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
Hidalgo M; Rowinsky EK
Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targets: MTOR and related pathways.
Dancey JE
Cancer Biol Ther; 2006 Sep; 5(9):1065-73. PubMed ID: 16969122
[TBL] [Abstract][Full Text] [Related]
6. Targeting the molecular target of rapamycin (mTOR).
Rowinsky EK
Curr Opin Oncol; 2004 Nov; 16(6):564-75. PubMed ID: 15627018
[TBL] [Abstract][Full Text] [Related]
7. Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer.
Chan S
Br J Cancer; 2004 Oct; 91(8):1420-4. PubMed ID: 15365568
[TBL] [Abstract][Full Text] [Related]
8. mTOR kinase inhibitors as a treatment strategy in hematological malignancies.
Grzybowska-Izydorczyk O; Smolewski P
Future Med Chem; 2012 Mar; 4(4):487-504. PubMed ID: 22416776
[TBL] [Abstract][Full Text] [Related]
9. The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy.
Janus A; Robak T; Smolewski P
Cell Mol Biol Lett; 2005; 10(3):479-98. PubMed ID: 16217558
[TBL] [Abstract][Full Text] [Related]
10. New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists.
Carraway H; Hidalgo M
Breast Cancer Res; 2004; 6(5):219-24. PubMed ID: 15318929
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
Gibbons JJ; Abraham RT; Yu K
Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
[TBL] [Abstract][Full Text] [Related]
12. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.
Albert S; Serova M; Dreyer C; Sablin MP; Faivre S; Raymond E
Expert Opin Investig Drugs; 2010 Aug; 19(8):919-30. PubMed ID: 20569080
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic.
Huang S; Houghton PJ
Curr Opin Investig Drugs; 2002 Feb; 3(2):295-304. PubMed ID: 12020063
[TBL] [Abstract][Full Text] [Related]
14. mTOR as a target for cancer therapy.
Houghton PJ; Huang S
Curr Top Microbiol Immunol; 2004; 279():339-59. PubMed ID: 14560967
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin as a target in hematological malignancies.
Kelly KR; Rowe JH; Padmanabhan S; Nawrocki ST; Carew JS
Target Oncol; 2011 Mar; 6(1):53-61. PubMed ID: 21499765
[TBL] [Abstract][Full Text] [Related]
16. mTOR in renal cell cancer: modulator of tumor biology and therapeutic target.
Wysocki PJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):231-41. PubMed ID: 19379082
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of mTOR inhibitor resistance in cancer therapy.
Carew JS; Kelly KR; Nawrocki ST
Target Oncol; 2011 Mar; 6(1):17-27. PubMed ID: 21547705
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.
Vincenzi B; Napolitano A; D'Onofrio L; Frezza AM; Silletta M; Venditti O; Santini D; Tonini G
Expert Opin Investig Drugs; 2011 Dec; 20(12):1685-705. PubMed ID: 22010859
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway.
Smolewski P
Anticancer Drugs; 2006 Jun; 17(5):487-94. PubMed ID: 16702804
[TBL] [Abstract][Full Text] [Related]
20. The mTOR pathway in breast cancer.
Hynes NE; Boulay A
J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):53-61. PubMed ID: 16900391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
